Mishra S, Kumari S, Husain N
J Liq Biopsy. 2025; 6:100280.
PMID: 40027313
PMC: 11863890.
DOI: 10.1016/j.jlb.2024.100280.
Yao H, Song W, Cao R, Ye C, Zhang L, Chen H
Nat Commun. 2022; 13(1):5506.
PMID: 36127339
PMC: 9489697.
DOI: 10.1038/s41467-022-33037-x.
DAfonseca V, Arencibia A, Echeverria-Vega A, Cerpa L, Cayun J, Varela N
Cancer Inform. 2020; 19:1176935120922154.
PMID: 32546937
PMC: 7249562.
DOI: 10.1177/1176935120922154.
Shi W, Jiang R, Liang F, Yu G, Long J, Zhao J
Cancer Manag Res. 2019; 11:5065-5073.
PMID: 31213918
PMC: 6549434.
DOI: 10.2147/CMAR.S202543.
Singh R, Goldberg J, Varghese A, Yu K, Park W, OReilly E
Cancer Treat Rev. 2019; 75:27-38.
PMID: 30927677
PMC: 6504563.
DOI: 10.1016/j.ctrv.2019.03.003.
Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine.
Conway J, Herrmann D, Evans T, Morton J, Timpson P
Gut. 2018; 68(4):742-758.
PMID: 30396902
PMC: 6580874.
DOI: 10.1136/gutjnl-2018-316822.
Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant Chemoradiation.
Herman J, Jabbour S, Lin S, Deek M, Hsu C, Fishman E
Pancreas. 2018; 47(2):208-212.
PMID: 29329157
PMC: 5800523.
DOI: 10.1097/MPA.0000000000000985.
Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC.
Colbert L, Moningi S, Chadha A, Amer A, Lee Y, Wolff R
Adv Radiat Oncol. 2017; 2(3):403-415.
PMID: 29114609
PMC: 5605283.
DOI: 10.1016/j.adro.2017.02.004.
TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma.
Thakur A, Nigri J, Lac S, Leca J, Bressy C, Berthezene P
Cell Death Differ. 2016; 23(8):1358-70.
PMID: 26943320
PMC: 4947667.
DOI: 10.1038/cdd.2016.18.
Pancreatic cancer and SBRT: A new potential option?.
Hajj C, Goodman K
Rep Pract Oncol Radiother. 2015; 20(5):377-84.
PMID: 26549996
PMC: 4597084.
DOI: 10.1016/j.rpor.2015.05.008.
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas.
Tone A, McConechy M, Yang W, Ding J, Yip S, Kong E
BMC Cancer. 2014; 14:982.
PMID: 25523272
PMC: 4320586.
DOI: 10.1186/1471-2407-14-982.
Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?.
Chuong M, Boggs D, Patel K, Regine W
J Gastrointest Oncol. 2014; 5(3):166-77.
PMID: 24982765
PMC: 4074954.
DOI: 10.3978/j.issn.2078-6891.2014.025.
